Stakeholders Rally for Sustainable Funding to Secure Australia's Future of National One Stop Shop for Clinical Trials

The NOSS, a pioneering digital platform, seeks to streamline the approval and reporting procedures for human research, particularly clinical trials, in Aus...

 February 06, 2024 | News

Sirius Therapeutics Begins Phase 1 Trial for Long-Acting Factor XI siRNA Anticoagulant

"This study is based on in vivo studies that have demonstrated a nearly 100% reduction in FXI levels for up to 6 months without bleeding events a...

 February 04, 2024 | News

Endogenex Receives IDE Approval to Initiate Pivotal Clinical Study

 Endogenex, Inc., a clinical stage medical device company dedicated to improving outcomes in patients with Type 2 Diabetes (T2D), announced that the U...

 January 31, 2024 | News

Australia's Island Pharma Advances ISLA-101 Study: Third Cohort Successfully Dosed

This achievement follows the recent confirmation from the Data Safety Review Committee that ISLA-101 has been deemed safe and well-tolerated in the 16 subj...

 January 23, 2024 | News

Life Sciences Queensland Welcomes Dr. Kym Baker and Dr. Denise Hodge to Board Leadership

Dr. Kym Baker, currently serving as the General Manager of Patheon Biologics at Thermo Fisher Scientific Brisbane Biologics site, brings over 30 years of e...

 January 23, 2024 | News

CSIRO Invites Australian SMEs to Join Innovate to Grow Program for Advancing Digital Health and Medical Tech

Australia’s CSIRO is actively seeking startups and small to medium-sized enterprises (SMEs) eager to drive innovation in digital health and medical t...

 January 23, 2024 | News

TGA Grants Approval to Australia's Pioneering RSV Vaccine, AREXVY

AREXVY has been approved by the Therapeutic Goods Administration (TGA) for Australians 60 and over to protect against lower airway infection caused by re...

 January 19, 2024 | Regulatory

Immunexpress' SeptiCyte RAPID® Gains TGA Clearance in Australia

Immunexpress, a molecular diagnostic company focused on improving outcomes for suspected sepsis patients, today announced that SeptiCyte® RAPID has rec...

 January 17, 2024 | News

Smith+Nephew Report Urges Overhaul of Musculoskeletal Injury Care and Reimbursement in Australia

  The Economist Impact - Musculoskeletal Injuries in Australia Report outlines the growing number of meniscal injury (MI) and rotator cuff (RC) injur...

 January 15, 2024 | News

Australia Achieves Positive Results in Phase Ib Study for Androgenic Alopecia Treatment

This study is led by Professor Rodney Sinclair and included 12 male and 4 female patients in Australia with androgenic alopecia (AGA). ...

 January 15, 2024 | News

GC Cell Initiates Phase 1 Trials for AB-201 Cancer Treatment with Lunit AI Platform

 GC Cell, a fully integrated cell therapy pioneer, is proud to announce the approval from both the Australian Human Research Ethics Committee (HREC) a...

 January 09, 2024 | News

Australia's GPN Vaccines Reports Positive Phase 1 Data for Gamma-PN Trial

In this double-blind, randomised study with placebo and active controls, 120 participants received either two doses of 50, 250 or 1000 micrograms of Gamma-...

 January 04, 2024 | News

Asieris' APL-2301 Approved for Phase I Trials in Australia for Acinetobacter baumannii Infection

The planned clinical trial in Australia will be the first-in-human Phase I trial for APL-2301. It aims to evaluate the safety, tolerability, phar...

 December 26, 2023 | News

Biocon Biologics Successfully Integrates Acquired Biosimilars Business Across 120 Countries

Biocon Biologics, a unique, fully integrated, global biosimilars company with a rich portfolio of insulins and monoclonal antibodies, has successfully conc...

 December 19, 2023 | News


Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox


Forgot your password?



Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in